Mayo Clinic looks at effect of CBD on malfunctioning stomach muscles and/or or nerves. Continue reading Mayo clinic looks at CBD for stomach problems
Tetra Bio-Pharma resumes and expands phase-3 trials, with its Serenity Study (c)
Continue reading SERENITY STUDY: CLINICAL TRIAL FOR CANCER-PAIN MEDICATION AT 40 NORTH AMERICAN SITES
Diseases of the gastrointestinal system, including cancer, are linked to the endocannabinoid system in humans, say researchers from Austria and Germany. Continue reading Cannabis, colon cancer and inflammatory bowel disease
Cannabis treatment significantly improved challenging behaviours in children suffering Autism Spectrum Disorder (ASD), says a new study done in Israel and published in the March issue of Journal of Autism Developmental Disorders.
Continue reading FEWER OUTBURSTS IN KIDS WITH AUTISM AFTER CANNABIS TREATMENT
New research out of Los Angeles found that men who have sex with men and also use cannabis, but no other mind-altering drugs, had significantly fewer sexually transmitted infections, including HIV Continue reading Fewer STDs among men-who-have-sex-with-men and also use cannabis.
Canaccord Genuity Growth Corp. (CGG) yesterday provided an update on its agreement with Columbia Care, a leading medical cannabis company in the United States.
CGG has obtained approval to extend the Escrow Release Deadline, as per an amendment of the subscription receipt agreement terms. Continue reading Escrow-release deadline extended for Canaccord deal with Columbia Care
Several studies on cannabis dependance & withdrawal, registered and completed as far back as 2013, were updated yesterday and today. Updated records show Jan 14 or 15 as last date the clinical trial met “Quality Control” criteria. Continue reading Multiple clinical-trial records on negative aspects of cannabis were updated this week.
Aurora sponsors cancer-pain study featuring MedReleaf capsules. Continue reading Aurora Cannabis sponsors cancer-pain study directed by internationally acclaimed oncologist.
Approximately 60 patients suffering breakthrough cancer pain to participate in clinical trial that compares fentanyl with inhaled medical cannabis. Continue reading UPDATED: Cannabis vs. fentanyl for cancer pain; clinical trial
Canaccord Genuity Growth Corp. complete reverse merger Continue reading Columbia Care and Canaccord Genuity Growth Corp. merger in Q1
Over the past half century or more, scientists and medical researchers have made hundreds of thousands of important discoveries about cannabis and its potential as medicine. Continue reading “OLD” CANNABIS RESEARCH FINALLY SEES THE LIGHT OF DAY. IT’S ABOUT TIME.
Approximately 136 US military veterans in the San Diego area will participate in a phase 2 clinical trial that will test the effects of CBD on Post-Traumatic-Stress Disorder. Continue reading Clinical trial: CBD for veterans with PTSD
CannTrust investing approx. CAD $6 million for 20% stake in Australian company Cannatrek. Continue reading CannTrust stakes claim in Australia
Inhaling cannabis makes for easier breathing, because it dilates – or opens up – the airways in the lungs, according to a 1973 study published in New England Journal of Medicine.
Continue reading BREATHING EASIER: SCIENTISTS DISCOVERED 46 YEARS AGO THAT INHALING CANNABIS OPENED UP AIRWAYS IN THE LUNGS
GW Pharmaceuticals’ research and development for the therapeutic use of cannabinoids dates back at least two decades.
Continue reading Patents granted to GW Pharmaceuticals for therapeutic use of cannabinoids
Aphria’s Australian-based partner Althea granted Manufacture Licence by the Australian Government’s Office of Drug Control.
Health Canada approval for next phase of vaporized cannabinoid drug clinical trial.
Clinical trial to start and finish by year end Continue reading Health Canada approves next phase of clinical trial to study Tetra Bio-Pharma’s vaporized cannabis drug
The University of Colorado School of Medicine is conducting a phase two clinical trial to determine if CBD can reduce symptoms of Parkinson’s disease
Continue reading Phase 2 clinical trial: CBD for Parkinsons
Fibromyalgia patients using cannabis saw dramatic improvement and astonished physicians w/ comments like “This is a miraculous treatment” & “I returned to same person I was before” Continue reading “Miraculous.” Cannabis dramatically improved fibromyalgia symptoms.
Heath Canada decision to reclassify, to a Phase Two medical device, the @TetraBioPharma inhalation pipe for cannabis medication means that patients suffering cancer pain may soon be able to claim the cost through their private and public insurance plans. Continue reading Health Canada makes Tetra Bio-Pharma cannabis-delivery product a Class Two medical device.
A University of Utah clinical trial is evaluating the effectiveness two different combinations of THC and CBD as treatment for chronic pain and life functioning. Continue reading Clinical trial: THC and CBD for chronic pain
@Tilray and McMaster to conduct clinical trial for anxiety disorders. Continue reading Tilray clinical trial for anxiety disorders
GW Pharmaceuticals is conducting a clinical trial on the effectiveness of its #CBD drug in treating tremors in #Parkinson’s Disease.
The company said it expects to complete the study in June 2019. Continue reading GW Pharma clinical trial for Parkinsons
Aphria and Canadian bio-technology company Rapid Dose Therapeutics have signed an MOU that Aphria will have exclusive global preferred rights to produce, distribute and sell QuickStrip(TM) products for cannabis markets around the world, once a definitive agreement is signed between the two companies in the near future. Continue reading Aphria signs deal; exclusive global partner for QuickStrip
Charlotte’s Web Holdings blasts past 52-wek high.
Continue reading Charlotte’s Web increased 150% three weeks after IPO
Nothing short of a total mind shift in how we treat addiction will solve the current opioid epidemic. Medical cannabinoids must be part of the solution. Continue reading CBD reduced heroin craving a week after the last dose, says renowned addictions specialist
Large clinical trial – King’s College London – seeks to affirm CBD as a treatment for psychosis..
“CBD has emerged as a promising candidate as it displays anti-anxiety and anti-psychotic like properties in animals and humans.” Continue reading Clinical trial in UK aims to confirm CBD as treatment for psychosis
@TetraBioPharma today announced a new CBD supply agreement with Alberta-based True North Cannabis.
True North will supply Tetra with high-quality, competitively priced CBD Continue reading Tetra strikes new deal; True North Cannabis to supply high-quality CBD
Drug company earning multi-millions on MS med containing only 2 ingredients – THC and CBD ready to launch epilepsy drug this fall & now racing to develop CBD drugs for schizophrenia, #autism & other hard-to treat diseases. Continue reading GWPH studying CBD for schizophrenia & other hard-to-treat diseases
TetraBioPharma is setting its sights on cannabinoid-based drugs for rare cancers and eye diseases as it moves deeper into US with multiple FDA submissions. #cannabis #cannabis4cancer #cannabiscures Continue reading Tetra targets rare cancers & eye disease in FDA submissions
“The literature is nearly unanimous in suggesting that cannabinoids and endocannabinoids reduce the progression of cancer in preclinical model systems,” Continue reading Research spanning multiple decades showed cannabis as potential cancer medicine.
An international research project led by McGill University will examine the potential of CanniMed CBD oil to treat chronic pain, and related anxiety and depression. Continue reading Aurora supporting study of CBD as treatment for pain, depression, anxiety
Scientific evidence of cannabinoids as safe, effective treatment for schizophrenia is so powerful, compelling and widespread that it’s almost indisputable.
Why did it take us so long to get here? Continue reading The shame of schizophrenia is ours; CBD suspected as good medicine for years
CBD has beneficial effects in patients with schizophrenia and may represent a new class of treatment for the disorder. Continue reading Robust medical research shows CBD quells psychosis and schizophrenia
Brand new research shows that if the body’s Anandamide levels can be prevented from falling, PTSD treatment may be more effective. Anandamide is the human cannabinoid that’s sometimes called the bliss molecule. The study shows that putting stress on the brain can cause a drop in Anandamide levels. On the other hand, protecting the brain from stress causes Anandamide levels to go up. The culprit causing the levels to fall is a fatty acid called FAAH. The FAAH hits parts of the brain involved in fear extinction, which means it’s nearly impossible to completely forget the cary or terrifying events that led … Continue reading Fatty acid hurts PTSD healing
The discovery of a new molecule that’s similar to the Anandamide molecule is creating a buzz. We already know that the cannabinoids CBD and THC are powerful anti-inflammatories. Now a new cannabinoid – PEA – has been found to benefit the gastrointestinal system. PEA reduces inflammation in the intestine when it connects with cannabinoid receptors CB1 and CB2 and the new kid on the block – CB3. No doubt – more discoveries to come! Copyright Notice ©CannabisFindings.com. 2018. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts … Continue reading New discovery: cannabinoid that reduces inflammation in the intestines.
Reducing bone erosion in Rheumatoid Arthritis by using the body’s own endocannabinoid system Continue reading Halting bone damage in Rheumatoid Arthritis by tapping the body’s own cannabinoids
A cannabis-derived drug that could reduce opioid fentanyl use for breakthrough cancer pain is one step closer thanks to Health Canada approval that will allow a clinical trial to begin in October. Continue reading Clinical trial will compare cannabis with fentanyl for rapid-onset cancer pain
New research shows that an extra dose of CBD can help reduce side effects of regular cannabis use.
Continue reading Extra dose of CBD helps the medicine go down
An “endocannabinoid deficiency” can lead to disease. Continue reading Waking up the cannabinoid system in your body
Anandamide activates the body’s cannabinoid receptors by bonding to them. Continue reading THE BLISS MOLECULE
Experimental research shows that cannabinoid receptors are increased in areas where lesions have formed in the brain. Continue reading Treating brain disease
Feeling light-headed or dizzy after marijuana use is one of the first signs that your cardiovascular system is in distress. Fainting is another. Continue reading Can inhaling cannabis be a heart hazard?
Stanley Brothers has created Charlotte’s Web Holdings and is seeking regulatory approval in Canada for a proposed initial public offering of its common shares.
It is anticipated that the Offering Price will be between C$6.00 and C$7.00 per Common Share.
Continue reading Charlotte’s Web Holdings IPO in the works
The potential healing properties of cannabis are becoming increasingly evident. Hundreds of thousands of studies have been done in search of better treatment for diseases involving just about every system and organ in the body.
Continue reading “Old” cannabis-plant research finally sees the light of day.
With an FDA nod to GW Pharma, the CBD-based anti-seizure medication Epilodex will be on the market before the end of 2018. First-of-its kind medical trial seizures in children with a rare, life-threatening type of epilepsy.
#cannabis Continue reading GW Pharma to market CBD child-epilepsy drug
more targeted treatments may help alleviate pain without dangerous side effects such as addiction.
Continue reading Targeting pain
The potential healing properties of cannabis extracts are becoming increasingly evident as scientists seek new and better treatment for diseases involving just about every system and organ in the body. Studies and clinical trials in the hundreds of thousands have been conducted or are underway. Continue reading What scientists know
Terpenes’ contribution to therapeutic effect of cannabinoids “may be significant,” says new paper published in Current Neuropharmacology. Continue reading Terpenes + cannabinoids could one day be new medicine for depression and mood disorders
Founded in 1863 through a congressional charter signed by President Lincoln, the National Academies of Sciences, Engineering and Medicine produced its report Health Effects of Marijuana and Cannabis-Derived Products in 2017. It found that : Continue reading Cannabis smoking doesn’t increase risk of getting head, neck and lung cancer, but tobacco use does.
Synthetic THC combiner Obsessive Compulsive Disorder: A marked reduction in symptoms, according to new research out of the New York State Psychiatric Institute.
Continue reading THC reduces OCD symptoms; study.
Dosing with a “Cannabis Herbal Extract” containing THC and other cannabinoids may be more effective than purified CBD alone, said researchers.
CanniMed® 1:20 was used in the clinical trial.
Continue reading CanniMed’s 1:20 product helped reduce seizures in kids; clinical trial.
The case for timely, affordable access to cannabis grows with more evidence and new discoveries.
Taken a step further, this notion logically leads to a discussion about medical-insurance coverage for cannabis medicine. Continue reading WHY INSURANCE COMPANIES MUST PAY FOR MEDICAL-CANNABIS EXPENSES
Experimental research out of Brazil has found that cannabinoids may be able to halt the growth and spread of glioblastoma, an aggressive and incurable form of brain cancer. Continue reading CANNABINOIDS HALT GROWTH AND SPREAD OF BRAIN CANCER